Sumitovant Biopharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2019-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.sumitovant.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Sumitovant Biopharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT05226923
- Locations
- 🇺🇸
PRA Health Sciences, Lenexa, Kansas, United States
News
No news found